Call Us08045477330
Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder
Trastuzumab Lyophilized Powder
Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder Trastuzumab Lyophilized Powder

Trastuzumab Lyophilized Powder

36595 INR/Gram

Product Details:

  • Indication Breast Cancer, Gastric Cancer (HER2-positive)
  • Dosage Form Lyophilized Powder for Injection
  • Salt Composition Trastuzumab
  • Enzyme Types Other
  • Feature High purity, specifically binds to HER2 receptor, lyophilized stable formulation
  • Ingredients Trastuzumab (active ingredient), Excipients (e.g., L-histidine, polysorbate 20, sucrose)
  • Application Intravenous Infusion
  • Click to View more
X

Trastuzumab Lyophilized Powder Price And Quantity

  • 36585.00 - 36595.00 INR/Gram
  • 1-50 Box
  • 36595 INR/Gram

Trastuzumab Lyophilized Powder Product Specifications

  • White to off-white, lyophilized cake or powder
  • Store at 2C8C (Refrigerated). Protect from light. Do not freeze.
  • Intravenous Infusion
  • Odorless
  • Approximately 6.0
  • High purity, specifically binds to HER2 receptor, lyophilized stable formulation
  • Trastuzumab
  • 24 Months
  • Breast Cancer, Gastric Cancer (HER2-positive)
  • Lyophilized Powder for Injection
  • Other
  • Not applicable (monoclonal antibody, not enzyme)
  • Not applicable (biotechnological production in mammalian cell cultures at 3637C)
  • Trastuzumab (active ingredient), Excipients (e.g., L-histidine, polysorbate 20, sucrose)

Trastuzumab Lyophilized Powder Trade Information

  • Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Cash in Advance (CID), Cheque
  • Free samples are available
  • Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa
  • Herceptin (trastuzumab) for injection is a sterile, white to pale yellow, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration

Product Description

Trastuzumab Lyophilized Powder

Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture which may contain the antibiotic gentamicin. Gentamicin is not detectable in the final product.. Reconstitution with 7.4 mL of sterile water for injection (SWFI) yields a solution containing 21 mg/mL trastuzumab that delivers 7.15 mL (150 mg trastuzumab), at a pH of approximately 6.


Precise HER2 Targeting Cancer Therapy

Trastuzumab is designed to specifically bind to the HER2 receptor on cancer cells, inhibiting tumor growth in HER2-positive breast and gastric cancers. This targeted approach offers a highly effective treatment option while minimizing damage to healthy cells. The product's high purity and robust manufacturing ensure consistent therapeutic outcomes.


Convenient Stable Formulation

Offered as a stable lyophilized powder, Trastuzumab maintains its efficacy when stored properly under refrigeration. The formulation allows for ease of storage, extended shelf life of 24 months, and reconstitution according to clinical dosing needs, providing flexibility for medical providers and patients alike.

FAQ's of Trastuzumab Lyophilized Powder:


Q: How should Trastuzumab Lyophilized Powder be prepared and administered?

A: Reconstitute the vial with Sterile Water for Injection-7.2 mL for the 150 mg vial or 20 mL for the 440 mg vial-then further dilute the reconstituted solution in an infusion bag containing 0.9% Sodium Chloride. Administration is via intravenous infusion, with the first dose over 90 minutes and subsequent infusions over 30-90 minutes.

Q: What are the main indications for using Trastuzumab?

A: Trastuzumab is indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric cancer, offering a targeted approach for these malignancies when prescribed by a qualified healthcare professional.

Q: When should cardiac monitoring be performed for patients receiving Trastuzumab?

A: Cardiac function should be evaluated before initiating Trastuzumab treatment and monitored regularly during therapy, as Trastuzumab poses a risk for cardiac toxicity. Patients with pre-existing heart conditions require extra caution and frequent assessment.

Q: Where should Trastuzumab Lyophilized Powder be stored prior to use?

A: The product must be stored at 2C-8C in a refrigerator, protected from light and not frozen. Proper storage ensures stability and preserves the therapeutic effectiveness of the lyophilized powder.

Q: What are the key benefits of Trastuzumab's lyophilized and recombinant formulation?

A: The lyophilized form provides stable long-term storage, while recombinant DNA technology ensures high purity and specificity for the HER2 receptor. This results in enhanced safety, efficacy, and consistency in cancer treatment.

Q: Is Trastuzumab suitable for all cancer patients?

A: Trastuzumab is only appropriate for patients with HER2-positive tumors, as determined by approved diagnostic tests. It is not suitable for individuals with hypersensitivity to trastuzumab or any of its excipients.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category